Jacob Hooker

Jacob Hooker is a highly accomplished professional in the field of biomedical imaging and therapeutics, currently serving as President and CEO of Sensorium Therapeutics and Co-Founder of Eikonizo Therapeutics. In addition to these roles, Jacob is a Scientific Advisor for multiple organizations including Rocket Science Health, Delix Therapeutics, Psy Therapeutics, and Entheos Labs. Jacob has held various academic positions at Harvard Medical School and Massachusetts General Hospital since 2009, where responsibilities include Scientific Director of the Lurie Center for Autism and Director of Radiochemistry at the Athinoula A. Martinos Center for Biomedical Imaging. Jacob completed a Ph.D. in Chemistry at the University of California, Berkeley, following a BS in Chemistry from North Carolina State University.